COVID-19

Regulating gene therapies: what can be learned from COVID-19? 1:46
Regulating gene therapies: what can be learned from COVID-19?
Nicole Faust • 9 Apr 2021
The future impact of COVID-19 on the gene therapy sector 2:12
The future impact of COVID-19 on the gene therapy sector
Nicole Faust • 9 Apr 2021
Looking ahead in the cell & gene therapy sector 2:09
Looking ahead in the cell & gene therapy sector
Mike Lehmicke • 17 Mar 2021
Investigating allogeneic iNKT cell therapy 8:28
Investigating allogeneic iNKT cell therapy
Marc van Dijk • 23 Feb 2021
The effect of COVID-19 on the experience of lymphoma patients undergoing CAR-T therapy 3:33
The effect of COVID-19 on the experience of lymphoma patients undergoing CAR-T therapy
Lorna Warwick • 8 Feb 2021
Progress in the face of COVID-19 1:37
Progress in the face of COVID-19
Janet Lambert • 5 Oct 2020
Spotlight on key sessions at the 2020 ARM Meeting on the Mesa 2:16
Spotlight on key sessions at the 2020 ARM Meeting on the Mesa
Paige Bischoff • 6 Oct 2020
Impact of COVID-19 on CAR T-cell therapies 4:27
Impact of COVID-19 on CAR T-cell therapies
David L. Porter • 17 Sep 2020
Respiratory pathology of COVID-19 and potential for MSCs 12:40
Respiratory pathology of COVID-19 and potential for MSCs
Mauro Krampera • 31 May 2020
MSC based approaches to COVID-19 8:25
MSC based approaches to COVID-19
Maroun Khoury • 31 May 2020
The content of VJRegenMed is intended for healthcare professionals